Physician Spotlight

I was honored to be featured as the Physician Spotlight in the "East Tennessee Medical News" this month since it is also American Diabetes Month. To read the article click here.

World Diabetes Day

Today is World Diabetes Day and a time to reflect upon the current state of diabetes. Significant strides have been made with improved pharmaceuticals to treat diabetes, a better understanding of the pathophysiology of diabetes, better access to care for people with diabetes, and improved technologies for self-monitoring of blood glucoses. However, with that being said there are still major hurdles that still need to be cleared including:

New American Association of Clinical Endocrinologists (AACE) Diabetes Treatment Guidelines Overview

The American Association of Clinical Endocrinologists (AACE) has released their new 2009 Diabetes Treatment Guidelines/Algorithm and I am very excited by the direction they have moved. I am in complete agreement with their stance to limit if not completely avoid the use of sulfonylureas and use more of the newer products that may preserve beta cell function. I also like the treatment guidelines being based on multiple factors including current glucose control/A1c level and whether of not the patient is newly diagnosed.

Monotherapy Indication for Byetta® (exenatide)

Byetta® (exenatide) has received a monotherapy indication from the Food and Drug Administration (FDA) indicating it can be used safely and effectively as a single diabetes agent to control blood glucoses. The main stumbling block will still be insurance carrier's willingness to cover Byetta® as monotherapy on their formularies with the safe and effective generic alternative, metformin, still being available for very minimal cost ($4.00-$5.00/month on most plans).

The Diabetes Expert feeds